Dr. Roumen Milev, MD
Claim this profileQueen's University
Affiliated Hospitals
Queen's University
Providence Care Hospital
Clinical Trials Roumen Milev, MD is currently running
Escitalopram + Brexpiprazole
for Depression
This is a study that will test a predictive biomarker algorithm based on results from a previous study. The goal of this study is to integrate clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episode (MDE).
Recruiting
3 awards
Phase 4
11 criteria
Master Platform
for Mood Disorders
Mood disorders such as depression and bipolar disorder affect over 350 million people around the world. While several effective treatments exist, it is often difficult to match the right treatment to an individual person. Repeated efforts to find the right treatment contribute to poor functioning, low quality of life, and prolongs the time it takes to get well. Most areas of medicine are able to use 'biomarkers' or clinical tests, blood tests, or imaging to help diagnose and treat illness. The search for biomarkers in mood disorders is advancing, but one roadblock to progress is the lack of large, standardized studies of mood disorders that are needed to accurately identify biomarkers. The aim of the ENABLE platform is to provide the Canadian neuroscience community a standardized way of collecting biomarker data from individuals with a range of mood disorders symptoms. In addition, this 'master clinical trial platform' framework will provide a pool of participants who can be recruited into biomarker-based clinical trials.
Recruiting
1 award
N/A
5 criteria
More about Roumen Milev, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Roumen Milev, MD has experience with
- Brexpiprazole
- Escitalopram
- Electroconvulsive Therapy
- Ketamine
- Anodal Transcranial Direct Current Stimulation (tDCS)
- Cognitive Training
Breakdown of trials Roumen Milev, MD has run
Depression
Major Depressive Disorder
Bipolar Disorder
Depression, Bipolar Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roumen Milev, MD specialize in?
Roumen Milev, MD focuses on Depression and Major Depressive Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Roumen Milev, MD currently recruiting for clinical trials?
Yes, Roumen Milev, MD is currently recruiting for 4 clinical trials in Kingston Ontario. If you're interested in participating, you should apply.
Are there any treatments that Roumen Milev, MD has studied deeply?
Yes, Roumen Milev, MD has studied treatments such as Brexpiprazole, Escitalopram, Electroconvulsive Therapy.
What is the best way to schedule an appointment with Roumen Milev, MD?
Apply for one of the trials that Roumen Milev, MD is conducting.
What is the office address of Roumen Milev, MD?
The office of Roumen Milev, MD is located at: Queen's University, Kingston, Ontario K7L4X3 Canada. This is the address for their practice at the Queen's University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.